Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
Medications available for the treatment of seasonal allergic conjunctivitis include
antihistamines. These medicines block the release of histamine, a substance in the body that
is released when an allergic reaction occurs. Novartis (NVS) has developed an eye drop
formulation of a well tried antihistamine called ketotifen. This study will compare the
efficacy and the tolerability of ketotifen eye drops with emedastine, which is a popular
treatment for seasonal allergic conjunctivitis in China.